Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Starting a company is like staring into the abyss and eating glass!
TMDI moves in a market with incredible barriers to entry! JNJ teaches
But we are close!
TMDI is a little hidden gem that can grow big!
Luck doesn't exist. There is only the moment when talent meets opportunity.
Elon is phenomenal!
Ah how I wish he would set his eyes on a little hidden gem ….
So okay?
THE BEST SPENT
ISRG MC 125 bilion
TMDI 185 milion
At these prices it is very advisable for a fund exposed in ISRG to hedge on TMDI!
Simeone buys
https://fintel.io/so/us/tmdi
I think 93 US and international patents issued
Timely manner!
despite this!
ah from there!
what do you think of an offer reserved for a partner? guess riddle: who will it be?
Everything after the finish line 4
Just before the IDE!
I await the call to the offer
that despite this they are on time!
timely manner
in my opinion that comment should be read with respect to the weaknesses of Sport!
Now doesn't Enos have those flaws?
https://titanmedicalinc.com/wp-content/uploads/2021/07/Surgical-Endoscopy-Article-2019-Enabling-Single-site-Laparoscopy.pdf
not all systems can boast of having been tested and improved!
oh finally we will have videos and opinions of those who used it!
I can not wait!
well, go short!
you will become a millionaire!
I would like to buy at low prices especially now!
come on honey sell!
Who cares if we don't sell, it's a safe horse for you!
Tell the truth, are you waiting for the Tapering?
Monetary policy is expansive even with Tapering .... so you have to wait for the Tightening ... but everything will be fine, in the end there is McNally who will give you a hand!
Sure!
OTB
Sorry about the shorts but nothing even the Chinese will not help you!
The evergrande bankruptcy has been defused for now!
Who said it was going to be the worst October ever ... source RK?
What catalyst can help you?
For the costs you have to wait for February...
I think that all funds that have invested in ISRG should be hedged on TMDI!
Certainly not playing short!
How can they believe they defend their investment by going short!
Simple caution!
Un huh uhhh! someone buys
https://fintel.io/sob/us/tmdi
everyone wants them cheap!
you too!
it seems to me that time is running out and the little ones hold!
ouch ouch ouch try harder or it only goes down if you sell!
everyone sees what they want to see versus what they can see!
I know it's hard for you to accept but it will be the truth!
OH MAMMAMIA!!!
that's why TMDI's MC is so unfair!
McNally will be our hero!
Linzagolix is the only GnRH antagonist to provide flexible dosing options to better address the individual needs of patients, and these results further underscore its differentiated profile and potential clinical utility.
the market is still cold
someone buys
https://fintel.io/sob/us/tmdi
A little piece of good news would be enough for a nice Short Tsunami
Here are the 5!
Very interesting if it goes under!
I would be tempted to open the position now!
Milestone 4 at any time!
also tomorrow!
O
T
B
do we have to fasten the seat belts?
ooooOOOOOoooooh!
Not sure if Titan applied for Breakthrough designation and was rejected by the FDA or they didn’t even bother applying knowing what they have….
it would have been nice to think about it before 1to1... it could be a question to ask even if I ignore the reason for the Breakthrough designation
Right now:
Perform additional software development and test system performance
Perform electrical safety testing for surgeon workstations and patient cart, including electromagnetic compatibility (EMC) and electromagnetic interference (EMI) tests at independent lab
Perform animal feasibility or GLP study
it seems they want to get over the 30s!
becomes interesting
Ebopiprant for treatment of preterm labor: Phase 2b dose ranging study initiation in EU/Asia (Q4:21)
Company plans to discuss with European regulators a possible accelerated registration program based on a Phase 2b/3 adaptive design.
Someone says 5 ... will it get there?
I would like to enter but of course they spend a lot on research and development... and for sell